Plain-English translation of NCT07764991 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing lactoferrin, a natural protein found in milk and body fluids, to see if it can help protect the kidneys of people with type 2 diabetes who have early kidney damage. Researchers believe this medication may reduce inflammation and oxidative stress—harmful processes that damage kidneys over time. The study will compare people who take lactoferrin alongside their regular diabetes medications with people who take a placebo (inactive pill) over 12 weeks.
Type 2 diabetes often damages the kidneys slowly, and current treatments don't fully stop this damage. Lab and animal studies suggest this medication has powerful anti-inflammatory and protective properties that could slow kidney disease, so researchers want to test whether it actually helps real patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will take either a lactoferrin supplement or a placebo pill once daily for 12 weeks, along with your regular diabetes medications. You'll be randomly assigned to one of these two groups. During the study, you'll have clinic visits to check your kidney function through blood and urine tests and to see how you're tolerating the medication. The main goal is to measure whether the treatment slows the protein loss in your urine and preserves your kidney function.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Egypt